FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

JW Hetherington

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Cora N Sternberg; P Whelan; JW Hetherington; B Paluchowska; Peter Slee; Kris Vekemans; P Van Erps; Christine Theodore; O Koriakine; T Oliver; D Lebwohl; Muriel Debois; Alfredo Zurlo; Laurence Collette
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer.
Paul J Kil; H M J Goldschmidt; B J A Wieggers; O B Kariakine; Urs E Studer; Peter Whelan; JW Hetherington; Theo M de Reijke; J W Hoekstra; Laurence Collette
Tissue polypeptide-specific antigen (TPS) determinations before and during intermittent maximal androgen blockade in patients with metastatic prostatic carcinoma.
Don W W Newling; JW Hetherington; S K Sundaram; MR Robinson; L Kisbenedek
The use of valrubicin for the chemoresection of superficial bladder cancer -- a marker lesion study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of JW Hetherington (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Cora N Sternberg; P Whelan; JW Hetherington; B Paluchowska; Peter Slee; Kris Vekemans; P Van Erps; Christine Theodore; O Koriakine; T Oliver; D Lebwohl; Muriel Debois; Alfredo Zurlo; Laurence Collette
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer.
Oncology 2005;68(1):2-9.
2003: Paul J Kil; H M J Goldschmidt; B J A Wieggers; O B Kariakine; Urs E Studer; Peter Whelan; JW Hetherington; Theo M de Reijke; J W Hoekstra; Laurence Collette
Tissue polypeptide-specific antigen (TPS) determinations before and during intermittent maximal androgen blockade in patients with metastatic prostatic carcinoma.
European urology 2003;43(1):31-8.
2001: Don W W Newling; JW Hetherington; S K Sundaram; MR Robinson; L Kisbenedek
The use of valrubicin for the chemoresection of superficial bladder cancer -- a marker lesion study.
European urology 2001;39(6):643-7.
2001: Sophie D Fosså; Peter Slee; Maurizio Brausi; Simon Horenblas; R R Hall; JW Hetherington; N Aaronson; Laurence Collette
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):62-71.
2000: Sophie D Fosså; Desmond Curran; N K Aaronson; FI Keuppens; J Kliment; MR Robinson; T M DeReijke; JW Hetherington; Paul J Kil; Lesley A Rea
Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893.
European urology 2000;37(5):541-51.
1998: Alan Horwich; Robert A Huddart; J Gadd; P J Boyd; JW Hetherington; Peter Whelan; David P Dearnaley
A pilot study of intermittent androgen deprivation in advanced prostate cancer.
British journal of urology 1998;81(1):96-9.